Clinical Trial Update: QEQ Treatment Responsiveness Evaluation Study [Phase 4]

View source ↗

Summary

Phase 4 study update evaluating QEQ treatment responsiveness in impotence (erectile dysfunction) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• QEQ

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Impotence | Phase 4 | Status: COMPLETED